A comprehensive understanding of the role of AP-1 and C/EBPβ in ETB receptor regulation in glaucoma would help develop molecular tools to control inappropriate ETB receptor expression for neuroprotective approaches in glaucoma. This evidence concerns the gene CEBPB and glaucoma.